Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:08:53 EST Sun 08 Nov 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-11-08 22:32U:PLCENews ReleaseThe Children's Place Commences Process to Effectuate Value-Maximizing Sale Transaction
2026-11-08 21:11U:GFRNews ReleaseGreenfire Resources Reports Third Quarter 2026 Results and Provides an Operational Update
2026-11-08 20:42U:FFRNews ReleaseFF EAI Robotics Ecosystem Inc. (FFR) and Faraday Future Announce FF OmniMind and Its Model Achieve No. 1 in RoboColiseum Embodied AI Model Ranking; Advance Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions
2026-11-08 20:06U:GTERNews ReleaseGloba Terra Acquisition Corporation Announces Definitive Business Combination Agreement with Nature's Ledger Inc. and Reaffirms November 9 Shareholder Extension Vote
2026-11-08 19:30U:FFRNews ReleaseFaraday Future and FFR Announce FF OmniMind and Its Model Achieves No. 1 in RoboColiseum Embodied AI Model Ranking; Advances Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions
2026-11-08 19:30U:FFAINews ReleaseFaraday Future and FFR Announce FF OmniMind and Its Model Achieves No. 1 in RoboColiseum Embodied AI Model Ranking; Advances Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions
2026-11-08 18:00U:MANENews ReleaseVeradermics to Hold Conference Call to Discuss 12-Month Long-Term Results from Phase 3 '302' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
2026-11-08 18:00U:EEGUFNews ReleaseBeetaloo Energy Australia Limited (EEGUF) Retention Licence Granted at Carpentaria Project
2026-11-08 17:35U:IMMPNews ReleaseIMP761 Late-Breaking Abstract at ACR Convergence 2026 Highlights Statistically Significant & Exposure-Dependent Inhibition of T-Cell-Driven Immune Responses
2026-11-08 16:55U:ELEKNews ReleasePenny Stock Lovers, Microcap Investors: This Is Your Time To Shine
2026-11-08 16:45U:VIRNews ReleaseVir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data
2026-11-08 16:35U:MLYSNews ReleaseMineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026
2026-11-08 16:23U:ELEKNews ReleaseMicrocap Investors, Penny Stock Enthusiasts: Your Time To Shine May Be Now
2026-11-08 16:15U:VIRNews ReleaseVir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta
2026-11-08 16:01U:RDNTNews ReleaseRadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
2026-11-08 16:00U:REGNNews ReleaseCIDEB siRNA Normalizes Liver Fat and Improves Liver Injury Markers in MASLD Patients, as Highlighted at AASLD
2026-11-08 15:33U:ELEKNews ReleaseTime Is of the Essence: Elektros Advances Development Efforts for Its Patented Multi-Port EV Charging Technology
2026-11-08 15:30U:RCELNews ReleaseAVITA Medical to Host Investor Webinar Briefing
2026-11-08 15:00U:NVDANews ReleaseStatement from NVIDIA Board of Directors
2026-11-08 12:45U:ABBVNews ReleaseAllergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
2026-11-08 11:00U:JNJNews ReleaseJohnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer
2026-11-08 10:30U:CRSPNews ReleaseCRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
2026-11-08 10:30U:CGEMNews ReleaseVelinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026
2026-11-08 10:00U:CABANews ReleaseCabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases
2026-11-08 04:56U:TZOONews ReleaseClub Offers for Travel Enthusiasts in Germany
2026-11-08 03:00U:TZOONews ReleaseClub Offers for Travel Enthusiasts in Canada
2026-11-08 00:00U:TZOONews ReleaseClub Offers for Travel Enthusiasts in the U.S.